Inventor · disambiguated record
Lena A. Basile
Also filed as: BASILE LENA A
8 granted patents·13 pending applications·47 citations·filing 2009–2021
82Inventor score
Top patents by PatentIndex Score
21 records- 0191US9636381B2Methods for radiation protection by administering IL-12NEUMEDICINES INC·Filed 2013·Granted May 2, 2017·32 cites·40 claims
- 0284US9616106B2IL-12 for radiation protection and radiation-induced toxicity mitigationNEUMEDICINES INC·Filed 2013·Granted Apr 11, 2017·10 cites·20 claims
- 0383US8735342B2Method for treating brain cancer using a novel tumor suppressor gene and secreted factorBASILE LENA A·Filed 2011·Granted May 27, 2014·4 cites·9 claims
- 0477US8921315B1Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12BASILE LENA A·Filed 2009·Granted Dec 30, 2014·1 cites·26 claims
- 0566US2022168393A1Il-12 compositions and methods of use in hematopoietic recoveryKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0664US9463219B2Method for treating brain cancer using a novel tumor suppressor gene and secreted factorNEUMEDICINES INC·Filed 2014·Granted Oct 11, 2016·0 cites·10 claims
- 0761US2015147294A1Use of il-12 to increase survivalNEUMEDICINES INC·Filed 2014·Application pending·0 cites
- 0860US2015110739A1Uses of il-12 and the il-12 receptor positive cell in tissue repair and regenerationNEUMEDICINES INC·Filed 2014·Application pending·0 cites
- 0959US8962317B2Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regenerationBASILE LENA A·Filed 2011·Granted Feb 24, 2015·0 cites·13 claims
- 1057US2020131240A1Use of il-12 to generate endogenous erythropoietinNEUMEDICINES INC·Filed 2019·Application pending·0 cites
- 1154US2018207237A1Il-12 formulations for enhancing hematopoiesisNEUMEDICINES INC·Filed 2018·Application pending·0 cites
- 1254US2020030412A1Il-12 compositions and methods of use in hematopoietic recoveryNEUMEDICINES INC·Filed 2019·Application pending·0 cites
- 1348US9925246B2Mitigation of cutaneous injury with IL-12BASILE LENA A·Filed 2012·Granted Mar 27, 2018·0 cites·29 claims
- 1447US9878012B2IL-12 formulations for enhancing hematopoiesisBASILE LENA A·Filed 2011·Granted Jan 30, 2018·0 cites·8 claims
- 1545US2016120948A1Il-12 compositions and methods of use in hematopoietic recoveryNEUMEDICINES INC·Filed 2015·Application pending·0 cites
- 1645US2014178335A1Use of il-12 to generate endogenous erythropoietinBASILE LENA A·Filed 2012·Application pending·0 cites
- 1742US2024181010A1Uses of il-12 as a replacement immunotherapeuticNEUMEDICINES INC·Filed 2017·Application pending·0 cites
- 1841US2016045569A1Endogenous vaccine for cancer and infectious diseasesNEUMEDICINES INC·Filed 2014·Application pending·0 cites
- 1937US2015343021A1Methods for treating cancer using compositions comprising hss1 and/or hsm1NEUMEDICINES INC·Filed 2015·Application pending·0 cites
- 2036US2012189577A1Use of il-12 to increase survival following acute exposure to ionizing radiationBASILE LENA A·Filed 2012·Application pending·0 cites
- 2132US2016120949A1Uses of il-12 in hematopoietic immunotherapy (hit)NEUMEDICINES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lena A. Basile files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →